BrainFulness
Treatment for Major Depression and Anxiety - with NO SIDE EFFECTS!
Startup Pre-Funding Health Tech & Life Sciences Est. 2015
Total Raised
$55K
Pre-Funding
Last Round
$55K
1 rounds
Team
4
1-10 employees
Confidence
97/100
Patents
1
About
BrainFulness has developed a new technology for treating major depression, ADHD, and dementia - with NO SIDE EFFECTS! The company has built a working prototype of its technology and registered for patents in Israel, the United States, Germany, and Japan. The prototype was approved for human use by the Israeli Health Ministry, and BrainFulness has completed a clinical trial on chronic, treatment-resistant patients, yielding encouraging results without side effects.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Platforms & InterfacesSoftware
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2C
Tags
medical-devicesmental-healthpatientsnon-invasiveconsumers
Funding & Events
Dec 2015
Non-equity $55K
Israel Innovation Authority
Details
Product Stage
R&D
Employees
1-10
Exact Count
3
District
Jerusalem District
Founded
2015
Registrar
515322899
Crunchbase
brainfulness
Locations
Agmon Street 2, Jerusalem
Links
Website
LinkedIn
Facebook
Admin
Last Update
Mar 26, 2025
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
funding rounds, news, markets
Team (4)
Prof. Haim Knobler
Founder & Advisor
Founder
abraham shoshani
Founder & Director
Founder
Gregory Katz
Medical Director
Nuriel Shoshani
Economist
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2018-12-03T00:00:00.000Z
Last editor
Natasha Voloshin (natashavolo@gmail.com)